Financial Architects, Inc Illumina, Inc. Transaction History

Financial Architects, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$268.51 - $400.74 $1,879 - $2,805	-7 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $40,579 - $49,700	-135 Reduced 95.07%	7 $3,000
Q1 2019 May 13, 2019	BUY	$272.57 - $321.18 $38,704 - $45,607	142 New	142 $44,000
Q1 2019 May 03, 2019	SELL	$272.57 - $321.18 $38,704 - $45,607	-142 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$272.46 - $366.54 $15,802 - $21,259	-58 Reduced 29.0%	142 $42,000
Q3 2018 Oct 29, 2018	BUY	$279.04 - $367.06 $11,440 - $15,049	41 Added 25.79%	200 $74,000
Q2 2018 Aug 03, 2018	BUY	$228.17 - $292.07 $28,293 - $36,216	124 Added 354.29%	159 $45,000
Q4 2017 Feb 12, 2018	SELL	$202.23 - $230.03 $70,780 - $80,510	-350 Reduced 90.91%	35 $8,000
Q3 2017 Nov 01, 2017	BUY	$172.3 - $213.93 $66,335 - $82,363	385	385 $77,000

968

151M

2.37M

1.41M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $14.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.